Pricing Log in Create free account

Aptevo Therapeutics Inc. (APVO) vs GRI Bio, Inc. (GRI)

Aptevo Therapeutics Inc. and GRI Bio, Inc. are both Biotechnology companies. Aptevo Therapeutics Inc. and GRI Bio, Inc. are of similar size ($3.1M and $3.1M). Aptevo Therapeutics Inc. trades at the lower P/E: 0.0× against 0.0×. Across the 10 metrics below, GRI Bio, Inc. leads on 6 and Aptevo Therapeutics Inc. on 4.

Valuation

Metric APVO GRI Biotechnology median
P/E 0.00 0.02 8.50
P/S 0.15 n/m 9.71
P/B 0.32 0.24 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 0.86 0.64
EV/Sales (0.34) n/m 9.21
Earnings yield 100,773.33% 5,408.03% (33.15%)
Free cash flow yield (1,315.16%) (418.56%) (25.50%)

Profitability

Metric APVO GRI Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (446.89%) (142.02%) (56.36%)
Return on assets (186.29%) (113.27%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric APVO GRI Biotechnology median
Revenue growth (TTM) 92.94% — 6.02%
EPS growth (last fiscal year) 99.72% 92.12% 30.26%
Revenue growth, 5-year CAGR (26.64%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric APVO GRI Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.08 10.30 4.72
Net debt to EBITDA 0.83 0.69 0.96

Dividend

Metric APVO GRI Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric APVO GRI Biotechnology median
Market cap 3.08m 3.06m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack